North America Multiplex Assays Market Companies Profiles, Size, Share, Growth, Trends and Forecast to 2026
North America multiplex assays market is expected to register a healthy CAGR of 7.4% in the forecast period of 2019 to 2026. The new market report contains data for historic years 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026.
Market Segmentation
By Products & Services (Reagents & Consumables, Instruments & Accessories, Software & Services), Type (Nucleic Acid Multiplex Assays, Protein Multiplex Assays, Cell-Based Multiplex Assays), Technology (Protein Microarray, Polymerase Chain Reaction, Multiplex Real-Time PCR, Flow Cytometry, Fluorescence Detection, Luminescence, Others), Application (Clinical Diagnostics, Research & Development), End User (Hospitals, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Research Institutes, Others), Geography (North America)
Major growing sectors under the Market Segmentation are as follows:
Market Segmentation
By Products & Services (Reagents & Consumables, Instruments & Accessories, Software & Services), Type (Nucleic Acid Multiplex Assays, Protein Multiplex Assays, Cell-Based Multiplex Assays), Technology (Protein Microarray, Polymerase Chain Reaction, Multiplex Real-Time PCR, Flow Cytometry, Fluorescence Detection, Luminescence, Others), Application (Clinical Diagnostics, Research & Development), End User (Hospitals, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Research Institutes, Others), Geography (North America)
Major growing sectors under the Market Segmentation are as follows:
- In products & services, reagents & consumables segment are dominating this market as the assays are widely accepted and applicable in various healthcare sectors the reagents & consumables holds the largest market share.
- In type, the nucleic acid multiplex assays are highly sensitive and specific to diagnose human diseases such as cancer, autoimmune or infectious diseases.
- In technology, the protein microarray is the emerging technology in the multiplex assays which offers characterization of hundreds of thousands of proteins in a highly parallel and high-throughput way. However, polymerase chain reaction is growing in the market due to its higher throughput and more information in fewer samples. As well as its time saving and cost effective.
- In application, clinical diagnostics is growing more as there number of diseases increasing these days and treatment experiment is carries out more to treat the same and these processes are carries out under diagnostics division.
- In end user, hospitals segment is growing as people suffering from problem visit hospitals as early as possible for the treatment. Increasing population visit hospitals with increase number of problems to get treated as early as possible and therefore the hospitals segment is growing higher as compare to other segment.
- BD
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific Inc.
- F. Hoffmann-La Roche Ltd
- Cepheid
- Siemens AG
- Hologic Inc.
- Luminex Corporation.
- MESO SCALE DIAGNOSTICS, LLC.
- QIAGEN
- PerkinElmer Inc.
- Illumina, Inc.
- AGENA BIOSCIENCE, INC.
- Olink
- Randox Laboratories Ltd.
- Bio-Techne.
- Agilent Technologies
- Sysmex Corporation
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA MULTIPLEX ASSAYS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHIC SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 RESEARCH METHODOLOGY
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 DBMR MARKET POSITION GRID
2.8 DBMR MARKET CHALLENGE MATRIX
2.9 THE CATEGORY VS TIME GRID
2.10 SECONDARY SOURCES
2.11 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.1.1 USE OF MULTIPLEX ASSAYS IN COMPANION DIAGNOSTICS
3.1.2 ADVANTAGES OVER SINGLEPLEX AND TRADITIONAL ASSAYS
3.1.3 INCREASING AWARENESS ABOUT MULTIFACTORIAL NATURE OF VARIOUS DISEASES
3.1.4 GROWING APPLICATIONS OF MULTIPLEX ASSAYS
3.2 RESTRAINTS
3.2.1 HIGH EQUIPMENT COSTS
3.2.2 STRINGENT REGULATIONS AND STANDARDS
3.3 OPPORTUNITIES
3.3.1 INCREASING VALIDATION OF BIOMARKERS IN MOLECULAR AND PROTEIN DIAGNOSTICS
3.3.2 NEWLY AVAILABLE OR LAUNCHED PANELS FOR THE ASSAYS
3.4 CHALLENGES
3.4.1 LACK OF PROFICIENT LABOUR TO HANDLE ADVANCED PROCEDURES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 NORTH AMERICA MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICES
6.1 OVERVIEW
6.2 REAGENTS & CONSUMABLES
6.3 INSTRUMENTS & ACCESSORIES
6.4 SOFTWARE & SERVICES
7 NORTH AMERICA MULTIPLEX ASSAYS MARKET, BY TYPE
7.1 OVERVIEW
7.2 NUCLEIC ACID MULTIPLEX ASSAYS
7.2.1 PLANAR NUCLEIC ASSAYS
7.2.2 BEAD-BASED NUCLEIC ASSAYS
7.3 PROTEIN MULTIPLEX ASSAYS
7.3.1 PLANAR PROTEIN ASSAYS
7.3.2 BEAD-BASED PROTEIN ASSAYS
7.4 CELL-BASED MULTIPLEX ASSAYS
8 NORTH AMERICA MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY
8.1 OVERVIEW
8.2 PROTEIN MICROARRAY
8.3 POLYMERASE CHAIN REACTION
8.4 MULTIPLEX REAL-TIME PCR
8.5 FLOW CYTOMETRY
8.6 FLUORESCENCE DETECTION
8.7 LUMINESCENCE
8.8 OTHERS
9 NORTH AMERICA MULTIPLEX ASSAYS MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 CLINICAL DIAGNOSTICS
9.2.1 CANCER
9.2.2 CARDIOVASCULAR DISEASES
9.2.3 METABOLISM & ENDOCRINOLOGY DISORDERS
9.2.4 INFECTIOUS DISEASES
9.2.5 NERVOUS SYSTEM DISORDERS
9.2.6 AUTOIMMUNE DISEASES
9.2.7 ALLERGIES
9.2.8 OTHERS
9.3 RESEARCH & DEVELOPMENT
9.3.1 DRUG DISCOVERY & DEVELOPMENT
9.3.2 BIOMARKER DISCOVERY & VALIDATION
10 NORTH AMERICA MULTIPLEX ASSAYS MARKET, BY END USER
10.1 OVERVIEW
10.2 HOSPITALS
10.3 CLINICAL LABORATORIES
10.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIE
10.5 RESEARCH INSTITUTES
10.6 OTHERS
11 NORTH AMERICA MULTIPLEX ASSAYS MARKET: BY GEOGRAPHY
11.1 NORTH AMERICA
11.1.1 U.S.
11.1.2 CANADA
11.1.3 MEXICO
12 NORTH AMERICA MULTIPLEX ASSAYS MARKET, COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
13 COMPANY PROFILE
13.1 THERMO FISHER SCIENTIFIC INC.
13.1.1 COMPANY SNAPSHOT
13.1.2 REVENUE ANALYSIS
13.1.3 COMPANY SHARE ANALYSIS
13.1.4 PRODUCT PORTFOLIO
13.1.5 RECENT DEVELOPMENTS
13.2 F. HOFFMANN-LA ROCHE LTD
13.2.1 COMPANY SNAPSHOT
13.2.2 REVENUE ANALYSIS
13.2.3 COMPANY SHARE ANALYSIS
13.2.4 PRODUCT PORTFOLIO
13.2.5 RECENT DEVELOPMENTS
13.3 BIO-RAD LABORATORIES, INC.
13.3.1 COMPANY SNAPSHOT
13.3.2 REVENUE ANALYSIS
13.3.3 COMPANY SHARE ANALYSIS
13.3.4 PRODUCT PORTFOLIO
13.3.5 RECENT DEVELOPMENTS
13.4 QIAGEN
13.4.1 COMPANY OVERVIEW
13.4.2 REVENUE ANALYSIS
13.4.3 COMPANY SHARE ANALYSIS
13.4.4 PRODUCT PORTFOLIO
13.4.5 RECENT DEVELOPMENTS
13.5 SIEMENS AG
13.5.1 COMPANY SNAPSHOT
13.5.2 REVENUE ANALYSIS
13.5.3 PRODUCT PORTFOLIO
13.5.4 RECENT DEVELOPMENTS
13.6 ABCAM PLC.
13.6.1 COMPANY SNAPSHOT
13.6.2 REVENUE ANALYSIS
13.6.3 PRODUCT PORTFOLIO
13.6.4 RECENT DEVELOPMENTS
13.7 AGENA BIOSCIENCE, INC.
13.7.1 COMPANY SNAPSHOT
13.7.2 GEOGRAPHICAL PRESENCE
13.7.3 PRODUCT PORTFOLIO
13.7.4 RECENT DEVELOPMENTS
13.8 AGILENT TECHNOLOGIES, INC.
13.8.1 COMPANY SNAPSHOT
13.8.2 REVENUE ANALYSIS
13.8.3 PRODUCT PORTFOLIO
13.8.4 RECENT DEVELOPMENTS
13.9 BD.
13.9.1 COMPANY SNAPSHOT
13.9.2 REVENUE ANALYSIS
13.9.3 PRODUCT PORTFOLIO
13.9.4 RECENT DEVELOPMENTS
13.10 BIO-TECHNE.
13.10.1 COMPANY SNAPSHOT
13.10.2 REVENUE ANALYSIS
13.10.3 PRODUCT PORTFOLIO
13.10.4 RECENT DEVELOPMENTS
13.11 BIOTEK INSTRUMENTS, INC.
13.11.1 COMPANY SNAPSHOT
13.11.2 GEOGRAPHICAL PRESENCE
13.11.3 PRODUCT PORTFOLIO
13.11.4 RECENT DEVELOPMENTS
13.12 HOLOGIC INC.
13.12.1 COMPANY SNAPSHOT
13.12.2 REVENUE ANALYSIS
13.12.3 PRODUCT PORTFOLIO
13.12.4 RECENT DEVELOPMENTS
13.13 ILLUMINA, INC.
13.13.1 COMPANY SNAPSHOT
13.13.2 REVENUE ANALYSIS
13.13.3 PRODUCT PORTFOLIO
13.13.4 RECENT DEVELOPMENTS
13.14 LUMINEX CORPORATION.
13.14.1 COMPANY SNAPSHOT
13.14.2 REVENUE ANALYSIS
13.14.3 PRODUCT PORTFOLIO
13.14.4 RECENT DEVELOPMENTS
13.15 MESO SCALE DIAGNOSTICS, LLC.
13.15.1 COMPANY SNAPSHOT
13.15.2 PRODUCT PORTFOLIO
13.15.3 RECENT DEVELOPMENTS
13.16 OLINK
13.16.1 COMPANY SNAPSHOT
13.16.2 GEOGRAPHICAL PRESENCE
13.16.3 PRODUCT PORTFOLIO
13.16.4 RECENT DEVELOPMENTS
13.17 PERKINELMER INC.
13.17.1 COMPANY SNAPSHOT
13.17.2 REVENUE ANALYSIS
13.17.3 PRODUCT PORTFOLIO
13.17.4 RECENT DEVELOPMENTS
13.18 QUANTERIX
13.18.1 COMPANY SNAPSHOT
13.18.2 REVENUE ANALYSIS
13.18.3 PRODUCT PORTFOLIO
13.18.4 RECENT DEVELOPMENTS
13.19 QUEST DIAGNOSTICS INCORPORATED.
13.19.1 COMPANY SNAPSHOT
13.19.2 REVENUE ANALYSIS
13.19.3 PRODUCT PORTFOLIO
13.19.4 RECENT DEVELOPMENTS
13.20 RANDOX LABORATORIES LTD.
13.20.1 COMPANY SNAPSHOT
13.20.2 GEOGRAPHICAL PRESENCE
13.20.3 PRODUCT PORTFOLIO
13.20.4 RECENT DEVELOPMENTS
13.21 SEEGENE INC.
13.21.1 COMPANY SNAPSHOT
13.21.2 REVENUE ANALYSIS
13.21.3 PRODUCT PORTFOLIO
13.21.4 RECENT DEVELOPMENTS
13.22 SYSMEX CORPORATION
13.22.1 COMPANY SNAPSHOT
13.22.2 REVENUE ANALYSIS
13.22.3 PRODUCT PORTFOLIO
13.22.4 RECENT DEVELOPMENTS
14 RELATED REPORTS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA MULTIPLEX ASSAYS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHIC SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 RESEARCH METHODOLOGY
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 DBMR MARKET POSITION GRID
2.8 DBMR MARKET CHALLENGE MATRIX
2.9 THE CATEGORY VS TIME GRID
2.10 SECONDARY SOURCES
2.11 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.1.1 USE OF MULTIPLEX ASSAYS IN COMPANION DIAGNOSTICS
3.1.2 ADVANTAGES OVER SINGLEPLEX AND TRADITIONAL ASSAYS
3.1.3 INCREASING AWARENESS ABOUT MULTIFACTORIAL NATURE OF VARIOUS DISEASES
3.1.4 GROWING APPLICATIONS OF MULTIPLEX ASSAYS
3.2 RESTRAINTS
3.2.1 HIGH EQUIPMENT COSTS
3.2.2 STRINGENT REGULATIONS AND STANDARDS
3.3 OPPORTUNITIES
3.3.1 INCREASING VALIDATION OF BIOMARKERS IN MOLECULAR AND PROTEIN DIAGNOSTICS
3.3.2 NEWLY AVAILABLE OR LAUNCHED PANELS FOR THE ASSAYS
3.4 CHALLENGES
3.4.1 LACK OF PROFICIENT LABOUR TO HANDLE ADVANCED PROCEDURES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 NORTH AMERICA MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICES
6.1 OVERVIEW
6.2 REAGENTS & CONSUMABLES
6.3 INSTRUMENTS & ACCESSORIES
6.4 SOFTWARE & SERVICES
7 NORTH AMERICA MULTIPLEX ASSAYS MARKET, BY TYPE
7.1 OVERVIEW
7.2 NUCLEIC ACID MULTIPLEX ASSAYS
7.2.1 PLANAR NUCLEIC ASSAYS
7.2.2 BEAD-BASED NUCLEIC ASSAYS
7.3 PROTEIN MULTIPLEX ASSAYS
7.3.1 PLANAR PROTEIN ASSAYS
7.3.2 BEAD-BASED PROTEIN ASSAYS
7.4 CELL-BASED MULTIPLEX ASSAYS
8 NORTH AMERICA MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY
8.1 OVERVIEW
8.2 PROTEIN MICROARRAY
8.3 POLYMERASE CHAIN REACTION
8.4 MULTIPLEX REAL-TIME PCR
8.5 FLOW CYTOMETRY
8.6 FLUORESCENCE DETECTION
8.7 LUMINESCENCE
8.8 OTHERS
9 NORTH AMERICA MULTIPLEX ASSAYS MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 CLINICAL DIAGNOSTICS
9.2.1 CANCER
9.2.2 CARDIOVASCULAR DISEASES
9.2.3 METABOLISM & ENDOCRINOLOGY DISORDERS
9.2.4 INFECTIOUS DISEASES
9.2.5 NERVOUS SYSTEM DISORDERS
9.2.6 AUTOIMMUNE DISEASES
9.2.7 ALLERGIES
9.2.8 OTHERS
9.3 RESEARCH & DEVELOPMENT
9.3.1 DRUG DISCOVERY & DEVELOPMENT
9.3.2 BIOMARKER DISCOVERY & VALIDATION
10 NORTH AMERICA MULTIPLEX ASSAYS MARKET, BY END USER
10.1 OVERVIEW
10.2 HOSPITALS
10.3 CLINICAL LABORATORIES
10.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIE
10.5 RESEARCH INSTITUTES
10.6 OTHERS
11 NORTH AMERICA MULTIPLEX ASSAYS MARKET: BY GEOGRAPHY
11.1 NORTH AMERICA
11.1.1 U.S.
11.1.2 CANADA
11.1.3 MEXICO
12 NORTH AMERICA MULTIPLEX ASSAYS MARKET, COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
13 COMPANY PROFILE
13.1 THERMO FISHER SCIENTIFIC INC.
13.1.1 COMPANY SNAPSHOT
13.1.2 REVENUE ANALYSIS
13.1.3 COMPANY SHARE ANALYSIS
13.1.4 PRODUCT PORTFOLIO
13.1.5 RECENT DEVELOPMENTS
13.2 F. HOFFMANN-LA ROCHE LTD
13.2.1 COMPANY SNAPSHOT
13.2.2 REVENUE ANALYSIS
13.2.3 COMPANY SHARE ANALYSIS
13.2.4 PRODUCT PORTFOLIO
13.2.5 RECENT DEVELOPMENTS
13.3 BIO-RAD LABORATORIES, INC.
13.3.1 COMPANY SNAPSHOT
13.3.2 REVENUE ANALYSIS
13.3.3 COMPANY SHARE ANALYSIS
13.3.4 PRODUCT PORTFOLIO
13.3.5 RECENT DEVELOPMENTS
13.4 QIAGEN
13.4.1 COMPANY OVERVIEW
13.4.2 REVENUE ANALYSIS
13.4.3 COMPANY SHARE ANALYSIS
13.4.4 PRODUCT PORTFOLIO
13.4.5 RECENT DEVELOPMENTS
13.5 SIEMENS AG
13.5.1 COMPANY SNAPSHOT
13.5.2 REVENUE ANALYSIS
13.5.3 PRODUCT PORTFOLIO
13.5.4 RECENT DEVELOPMENTS
13.6 ABCAM PLC.
13.6.1 COMPANY SNAPSHOT
13.6.2 REVENUE ANALYSIS
13.6.3 PRODUCT PORTFOLIO
13.6.4 RECENT DEVELOPMENTS
13.7 AGENA BIOSCIENCE, INC.
13.7.1 COMPANY SNAPSHOT
13.7.2 GEOGRAPHICAL PRESENCE
13.7.3 PRODUCT PORTFOLIO
13.7.4 RECENT DEVELOPMENTS
13.8 AGILENT TECHNOLOGIES, INC.
13.8.1 COMPANY SNAPSHOT
13.8.2 REVENUE ANALYSIS
13.8.3 PRODUCT PORTFOLIO
13.8.4 RECENT DEVELOPMENTS
13.9 BD.
13.9.1 COMPANY SNAPSHOT
13.9.2 REVENUE ANALYSIS
13.9.3 PRODUCT PORTFOLIO
13.9.4 RECENT DEVELOPMENTS
13.10 BIO-TECHNE.
13.10.1 COMPANY SNAPSHOT
13.10.2 REVENUE ANALYSIS
13.10.3 PRODUCT PORTFOLIO
13.10.4 RECENT DEVELOPMENTS
13.11 BIOTEK INSTRUMENTS, INC.
13.11.1 COMPANY SNAPSHOT
13.11.2 GEOGRAPHICAL PRESENCE
13.11.3 PRODUCT PORTFOLIO
13.11.4 RECENT DEVELOPMENTS
13.12 HOLOGIC INC.
13.12.1 COMPANY SNAPSHOT
13.12.2 REVENUE ANALYSIS
13.12.3 PRODUCT PORTFOLIO
13.12.4 RECENT DEVELOPMENTS
13.13 ILLUMINA, INC.
13.13.1 COMPANY SNAPSHOT
13.13.2 REVENUE ANALYSIS
13.13.3 PRODUCT PORTFOLIO
13.13.4 RECENT DEVELOPMENTS
13.14 LUMINEX CORPORATION.
13.14.1 COMPANY SNAPSHOT
13.14.2 REVENUE ANALYSIS
13.14.3 PRODUCT PORTFOLIO
13.14.4 RECENT DEVELOPMENTS
13.15 MESO SCALE DIAGNOSTICS, LLC.
13.15.1 COMPANY SNAPSHOT
13.15.2 PRODUCT PORTFOLIO
13.15.3 RECENT DEVELOPMENTS
13.16 OLINK
13.16.1 COMPANY SNAPSHOT
13.16.2 GEOGRAPHICAL PRESENCE
13.16.3 PRODUCT PORTFOLIO
13.16.4 RECENT DEVELOPMENTS
13.17 PERKINELMER INC.
13.17.1 COMPANY SNAPSHOT
13.17.2 REVENUE ANALYSIS
13.17.3 PRODUCT PORTFOLIO
13.17.4 RECENT DEVELOPMENTS
13.18 QUANTERIX
13.18.1 COMPANY SNAPSHOT
13.18.2 REVENUE ANALYSIS
13.18.3 PRODUCT PORTFOLIO
13.18.4 RECENT DEVELOPMENTS
13.19 QUEST DIAGNOSTICS INCORPORATED.
13.19.1 COMPANY SNAPSHOT
13.19.2 REVENUE ANALYSIS
13.19.3 PRODUCT PORTFOLIO
13.19.4 RECENT DEVELOPMENTS
13.20 RANDOX LABORATORIES LTD.
13.20.1 COMPANY SNAPSHOT
13.20.2 GEOGRAPHICAL PRESENCE
13.20.3 PRODUCT PORTFOLIO
13.20.4 RECENT DEVELOPMENTS
13.21 SEEGENE INC.
13.21.1 COMPANY SNAPSHOT
13.21.2 REVENUE ANALYSIS
13.21.3 PRODUCT PORTFOLIO
13.21.4 RECENT DEVELOPMENTS
13.22 SYSMEX CORPORATION
13.22.1 COMPANY SNAPSHOT
13.22.2 REVENUE ANALYSIS
13.22.3 PRODUCT PORTFOLIO
13.22.4 RECENT DEVELOPMENTS
14 RELATED REPORTS
LIST OF TABLES
Table 1 COST OF FEW MULTIPLEX INSTRUMENTS
Table 2 NORTH AMERICA MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION)
Table 3 NORTH AMERICA REAGENTS & CONSUMABLES IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 4 NORTH AMERICA INSTRUMENTS & ACCESSORIES IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 5 NORTH AMERICA INSTRUMENTS & ACCESSORIES IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 6 NORTH AMERICA MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
Table 7 NORTH AMERICA NUCLEIC ACID MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
Table 8 NORTH AMERICA NUCLEIC ACID MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 9 NORTH AMERICA PROTEIN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
Table 10 NORTH AMERICA PROTEIN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 11 NORTH AMERICA CELL-BASED MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 12 NORTH AMERICA MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
Table 13 NORTH AMERICA PROTEIN MICROARRAY IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 14 NORTH AMERICA POLYMERASE CHAIN REACTION IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 15 NORTH AMERICA MULTIPLEX REAL-TIME PCR IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 16 NORTH AMERICA FLOW CYTOMETRY IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 17 NORTH AMERICA FLUORESCENCE DETECTION IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 18 NORTH AMERICA LUMINESCENCE IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 19 NORTH AMERICA OTHERS IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 20 NORTH AMERICA MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
Table 21 NORTH AMERICA CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 22 NORTH AMERICA CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
Table 23 NORTH AMERICA RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 24 NORTH AMERICA RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
Table 25 NORTH AMERICA MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
Table 26 NORTH AMERICA HOSPITALS IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 27 NORTH AMERICA CLINICAL LABORATORIES IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 28 NORTH AMERICA PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 29 NORTH AMERICA RESEARCH INSTITUTES IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 30 NORTH AMERICA OTHERS IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 31 NORTH AMERICA MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 32 NORTH AMERICA MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION)
Table 33 NORTH AMERICA MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
Table 34 NORTH AMERICA NUCLEIC ACID MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
Table 35 NORTH AMERICA PROTEIN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
Table 36 NORTH AMERICA MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
Table 37 NORTH AMERICA MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
Table 38 NORTH AMERICA CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
Table 39 NORTH AMERICA RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
Table 40 NORTH AMERICA MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
Table 41 U.S. MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION)
Table 42 U.S. MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
Table 43 U.S. NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
Table 44 U.S. PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
Table 45 U.S. MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
Table 46 U.S. MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
Table 47 U.S. CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
Table 48 U.S. RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
Table 49 U.S. MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
Table 50 CANADA MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION)
Table 51 CANADA MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
Table 52 CANADA NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
Table 53 CANADA PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
Table 54 CANADA MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
Table 55 CANADA MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
Table 56 CANADA CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
Table 57 CANADA RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
Table 58 CANADA MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
Table 59 MEXICO MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION)
Table 60 MEXICO MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
Table 61 MEXICO NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
Table 62 MEXICO PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
Table 63 MEXICO MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
Table 64 MEXICO MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
Table 65 MEXICO CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
Table 66 MEXICO RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
Table 67 MEXICO MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
Table 1 COST OF FEW MULTIPLEX INSTRUMENTS
Table 2 NORTH AMERICA MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION)
Table 3 NORTH AMERICA REAGENTS & CONSUMABLES IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 4 NORTH AMERICA INSTRUMENTS & ACCESSORIES IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 5 NORTH AMERICA INSTRUMENTS & ACCESSORIES IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 6 NORTH AMERICA MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
Table 7 NORTH AMERICA NUCLEIC ACID MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
Table 8 NORTH AMERICA NUCLEIC ACID MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 9 NORTH AMERICA PROTEIN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
Table 10 NORTH AMERICA PROTEIN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 11 NORTH AMERICA CELL-BASED MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 12 NORTH AMERICA MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
Table 13 NORTH AMERICA PROTEIN MICROARRAY IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 14 NORTH AMERICA POLYMERASE CHAIN REACTION IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 15 NORTH AMERICA MULTIPLEX REAL-TIME PCR IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 16 NORTH AMERICA FLOW CYTOMETRY IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 17 NORTH AMERICA FLUORESCENCE DETECTION IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 18 NORTH AMERICA LUMINESCENCE IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 19 NORTH AMERICA OTHERS IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 20 NORTH AMERICA MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
Table 21 NORTH AMERICA CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 22 NORTH AMERICA CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
Table 23 NORTH AMERICA RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 24 NORTH AMERICA RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
Table 25 NORTH AMERICA MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
Table 26 NORTH AMERICA HOSPITALS IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 27 NORTH AMERICA CLINICAL LABORATORIES IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 28 NORTH AMERICA PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 29 NORTH AMERICA RESEARCH INSTITUTES IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 30 NORTH AMERICA OTHERS IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 31 NORTH AMERICA MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 32 NORTH AMERICA MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION)
Table 33 NORTH AMERICA MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
Table 34 NORTH AMERICA NUCLEIC ACID MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
Table 35 NORTH AMERICA PROTEIN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
Table 36 NORTH AMERICA MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
Table 37 NORTH AMERICA MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
Table 38 NORTH AMERICA CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
Table 39 NORTH AMERICA RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
Table 40 NORTH AMERICA MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
Table 41 U.S. MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION)
Table 42 U.S. MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
Table 43 U.S. NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
Table 44 U.S. PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
Table 45 U.S. MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
Table 46 U.S. MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
Table 47 U.S. CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
Table 48 U.S. RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
Table 49 U.S. MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
Table 50 CANADA MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION)
Table 51 CANADA MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
Table 52 CANADA NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
Table 53 CANADA PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
Table 54 CANADA MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
Table 55 CANADA MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
Table 56 CANADA CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
Table 57 CANADA RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
Table 58 CANADA MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
Table 59 MEXICO MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION)
Table 60 MEXICO MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
Table 61 MEXICO NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
Table 62 MEXICO PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
Table 63 MEXICO MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
Table 64 MEXICO MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
Table 65 MEXICO CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
Table 66 MEXICO RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
Table 67 MEXICO MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
LIST OF FIGURES
Figure 1 NORTH AMERICA MULTIPLEX ASSAYS MARKET: SEGMENTATION
Figure 2 NORTH AMERICA MULTIPLEX ASSAYS MARKET: DATA TRIANGULATION
Figure 3 NORTH AMERICA MULTIPLEX ASSAYS MARKET: DROC ANALYSIS
Figure 4 NORTH AMERICA MULTIPLEX ASSAYS MARKET: BOTTOM UP APPROACH
Figure 5 NORTH AMERICA MULTIPLEX ASSAYS MARKET: TOP DOWN APPROACH
Figure 6 NORTH AMERICA MULTIPLEX ASSAYS MARKET: INTERVIEW DEMOGRAPHICS
Figure 7 NORTH AMERICA MULTIPLEX ASSAYS MARKET: DBMR MARKET POSITION GRID
Figure 8 NORTH AMERICA MULTIPLEX ASSAYS MARKET: THE MARKET CHALLENGE MATRIX
Figure 9 NORTH AMERICA MULTIPLEX ASSAYS MARKET: THE CATEGORY VS TIME GRID
Figure 10 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF NORTH AMERICA MULTIPLEX ASSAYS MARKET
Figure 11 NORTH AMERICA MULTIPLEX ASSAYS MARKET: SEGMENTATION
Figure 12 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE MULTIPLEX ASSAYS MARKET AND ASIA PACIFIC IS ESTIMATED TO BE INCREASING WITH THE STRONG CAGR IN THE FORECAST PERIOD FROM 2019 TO 2026
Figure 13 USE OF MULTIPLEX ASSAYS IN COMPANION DIAGNOSTICS AND ADVANTAGES OVER SINGLEPLEX AND TRADITIONAL ASSAYS TO DRIVE THE MARKET FOR MULTIPLEX ASSAYS MARKET IN THE FORECAST PERIOD 2019 TO 2026
Figure 14 REAGENTS & CONSUMABLES IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MULTIPLEX ASSAYS MARKET IN 2019 & 2026
Figure 15 NORTH AMERICA MULTIPLEX ASSAYS MARKET: BY PRODUCT & SERVICES, 2018
Figure 16 NORTH AMERICA MULTIPLEX ASSAYS MARKET: BY TYPE, 2018
Figure 17 NORTH AMERICA MULTIPLEX ASSAYS MARKET: BY TECHNOLOGY, 2018
Figure 18 NORTH AMERICA MULTIPLEX ASSAYS MARKET: BY APPLICATION, 2018
Figure 19 NORTH AMERICA MULTIPLEX ASSAYS MARKET: BY END USER, 2018
Figure 20 NORTH AMERICA MULTIPLEX ASSAYS MARKET SNAPSHOT (2018)
Figure 21 NORTH AMERICA MULTIPLEX ASSAYS MARKET: BY GEOGRAPHY (2018)
Figure 22 NORTH AMERICA MULTIPLEX ASSAYS MARKET: BY GEOGRAPHY (2019-2026)
Figure 23 NORTH AMERICA MULTIPLEX ASSAYS MARKET: BY COUNTRY (2018 & 2026)
Figure 24 NORTH AMERICA MULTIPLEX ASSAYS MARKET: BY PRODUCTS & SERVICES (2019 - 2026)
Figure 25 NORTH AMERICA MULTIPLEX ASSAYS MARKET: COMPANY SHARE 2018 (%)
Figure 1 NORTH AMERICA MULTIPLEX ASSAYS MARKET: SEGMENTATION
Figure 2 NORTH AMERICA MULTIPLEX ASSAYS MARKET: DATA TRIANGULATION
Figure 3 NORTH AMERICA MULTIPLEX ASSAYS MARKET: DROC ANALYSIS
Figure 4 NORTH AMERICA MULTIPLEX ASSAYS MARKET: BOTTOM UP APPROACH
Figure 5 NORTH AMERICA MULTIPLEX ASSAYS MARKET: TOP DOWN APPROACH
Figure 6 NORTH AMERICA MULTIPLEX ASSAYS MARKET: INTERVIEW DEMOGRAPHICS
Figure 7 NORTH AMERICA MULTIPLEX ASSAYS MARKET: DBMR MARKET POSITION GRID
Figure 8 NORTH AMERICA MULTIPLEX ASSAYS MARKET: THE MARKET CHALLENGE MATRIX
Figure 9 NORTH AMERICA MULTIPLEX ASSAYS MARKET: THE CATEGORY VS TIME GRID
Figure 10 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF NORTH AMERICA MULTIPLEX ASSAYS MARKET
Figure 11 NORTH AMERICA MULTIPLEX ASSAYS MARKET: SEGMENTATION
Figure 12 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE MULTIPLEX ASSAYS MARKET AND ASIA PACIFIC IS ESTIMATED TO BE INCREASING WITH THE STRONG CAGR IN THE FORECAST PERIOD FROM 2019 TO 2026
Figure 13 USE OF MULTIPLEX ASSAYS IN COMPANION DIAGNOSTICS AND ADVANTAGES OVER SINGLEPLEX AND TRADITIONAL ASSAYS TO DRIVE THE MARKET FOR MULTIPLEX ASSAYS MARKET IN THE FORECAST PERIOD 2019 TO 2026
Figure 14 REAGENTS & CONSUMABLES IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MULTIPLEX ASSAYS MARKET IN 2019 & 2026
Figure 15 NORTH AMERICA MULTIPLEX ASSAYS MARKET: BY PRODUCT & SERVICES, 2018
Figure 16 NORTH AMERICA MULTIPLEX ASSAYS MARKET: BY TYPE, 2018
Figure 17 NORTH AMERICA MULTIPLEX ASSAYS MARKET: BY TECHNOLOGY, 2018
Figure 18 NORTH AMERICA MULTIPLEX ASSAYS MARKET: BY APPLICATION, 2018
Figure 19 NORTH AMERICA MULTIPLEX ASSAYS MARKET: BY END USER, 2018
Figure 20 NORTH AMERICA MULTIPLEX ASSAYS MARKET SNAPSHOT (2018)
Figure 21 NORTH AMERICA MULTIPLEX ASSAYS MARKET: BY GEOGRAPHY (2018)
Figure 22 NORTH AMERICA MULTIPLEX ASSAYS MARKET: BY GEOGRAPHY (2019-2026)
Figure 23 NORTH AMERICA MULTIPLEX ASSAYS MARKET: BY COUNTRY (2018 & 2026)
Figure 24 NORTH AMERICA MULTIPLEX ASSAYS MARKET: BY PRODUCTS & SERVICES (2019 - 2026)
Figure 25 NORTH AMERICA MULTIPLEX ASSAYS MARKET: COMPANY SHARE 2018 (%)
